Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Mursla Bio
Mursla Bio Publishes Peer-Reviewed Validation of Tissue-Specific Extracellular Vesicle Platform for Liquid Biopsy
Today 4:00 EDT
From
Mursla Bio
Via
Business Wire
Mursla Bio Accelerates US Commercial Deployment of EvoLiver Through ABHI Programme
March 04, 2026
From
Mursla Bio
Via
Business Wire
Mursla Bio Collaborates With a Leading Global Pharma Company to Advance Biomarker-guided Precision Medicine in MASH
November 13, 2025
From
Mursla Bio
Via
Business Wire
Mursla Bio Introduces AI Precision Medicine Platform Built on Organ-Specific EV Isolation from Blood
June 17, 2025
From
Mursla Bio
Via
Business Wire
Mursla Bio Receives FDA Breakthrough Device Designation for EvoLiver Test
April 23, 2025
From
Mursla Bio
Via
Business Wire
Mursla Bio’s EvoLiver Surpasses Current Standards in Liver Cancer Surveillance, Data Presented at AASLD Liver Meeting 2024
November 18, 2024
From
Mursla Bio
Via
Business Wire
Mursla Bio Joins Leading European Consortium to Advance Clinical Applications Based on Extracellular Vesicle Science
November 12, 2024
From
Mursla Bio
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.